138: Cutaneous Necrotizing Venulitis Flashcards
What is the most common subtype of cutaneous vasculitis?
The most common subtype of cutaneous vasculitis is cutaneous small-vessel vasculitis (45%) and IgA vasculitis (30%). Age >65 is associated with shorter survival.
What are the common infectious agents associated with cutaneous necrotizing venulitis?
Common infectious agents include: β-hemolytic Streptococcus, Staphylococcus aureus, Mycobacterium leprae, Neisseria meningitidis, Neisseria gonorrhoeae, Pseudomonas, Haemophilus influenzae, Rickettsia, Candida, and Rocky Mountain spotted fever.
What are the characteristic features of lesions in cutaneous necrotizing venulitis?
The characteristic features of lesions include polymorphous lesions, palpable purpura, erythematous to violaceous papules that do not blanch when pressed, and lesions that persist for 1-4 weeks and can resolve with hyperpigmentation and atrophic scars.
What is the most consistent abnormal laboratory finding in the diagnosis of cutaneous necrotizing venulitis?
The most consistent abnormal laboratory finding is an elevated ESR (Erythrocyte Sedimentation Rate).
What are the management strategies for cutaneous necrotizing venulitis?
Management strategies include: 1. H1 antihistamines 2. NSAIDs 3. Colchicine 4. Dapsone or hydroxychloroquine 5. If no response, consider systemic glucocorticoids, azathioprine, methotrexate, cyclosporine, mycophenolate mofetil, cyclophosphamide, plasmapheresis, intravenous immunoglobulin, infliximab, adalimumab, etanercept, and rituximab 6. For Hepatitis C: interferon-α 7. For Schnitzler syndrome: IL-1 inhibitors (anakinra, canakinumab, rilonacept) 8. For livedoid vasculitis: + stockings.
Which chronic disorders are associated with cutaneous necrotizing venulitis?
Associated chronic disorders include: Systemic Lupus Erythematosus, Sjögren Syndrome, Hypergammaglobulinemic Purpura, Dermatomyositis, Paraneoplastic Vasculitis, Cryoglobulins, Microscopic Polyangiitis, and others like Cystic fibrosis, Inflammatory bowel diseases, and Behçet disease.
What is the likely diagnosis for a 70-year-old patient with palpable purpura and elevated ESR?
The likely diagnosis is Cutaneous Necrotizing Venulitis. Systemic involvements to evaluate include synovia, GI tract, voluntary muscles, peripheral nerves, and kidneys.
What is the underlying mechanism for mixed cryoglobulinemia in a patient with hepatitis C?
The underlying mechanism involves immune complex deposition. The types of cryoglobulins involved are mixed types II and III.
What is the likely cause of hyperpigmentation and cutaneous ulcers in a patient with Sjögren Syndrome?
The likely cause is Cutaneous Necrotizing Venulitis associated with Sjögren Syndrome. Other systemic features might include articular involvement, peripheral neuropathy, Raynaud phenomenon, and renal involvement.
What does vasculitis of the GI tract indicate in a child with dermatomyositis?
This finding indicates systemic involvement of dermatomyositis. Complications to monitor include GI bleeding and perforation.
What antibody is associated with a higher risk of Cutaneous Necrotizing Venulitis in SLE patients?
The anti-Ro antibody is associated with a higher risk of Cutaneous Necrotizing Venulitis in patients with SLE.
What is the diagnosis for a patient with palpable purpura and IgA deposition around blood vessels?
The diagnosis is IgA vasculitis. The dominant subclass of IgA is IgA1.
What are the next-line treatment options for a patient unresponsive to NSAIDs and colchicine?
Next-line treatment options include systemic glucocorticoids, azathioprine, methotrexate, cyclosporine, mycophenolate mofetil, cyclophosphamide, plasmapheresis, intravenous immunoglobulin, infliximab, adalimumab, etanercept, and rituximab.
What specific antiviral therapy should be considered for a patient with hepatitis C and Cutaneous Necrotizing Venulitis?
Interferon-α should be considered for treating hepatitis C in the context of Cutaneous Necrotizing Venulitis.
What targeted therapy is recommended for a patient with Schnitzler Syndrome?
IL-1 inhibitors such as anakinra, canakinumab, or rilonacept are recommended for Schnitzler Syndrome.
What supportive therapy can help manage symptoms in a patient with livedoid vasculopathy?
Supportive therapy includes the use of compression stockings.
What laboratory test is most likely to be positive in a patient with microscopic polyangiitis?
ANCAs (antineutrophil cytoplasmic antibodies) are most likely to be positive in microscopic polyangiitis.
What is the causative organism in a patient with erythema nodosum leprosum and necrotizing vasculitis?
The causative organism is Mycobacterium leprae.
What is the diagnosis for a patient with a biopsy showing neutrophilic infiltrates and nuclear debris?
The diagnosis is Cutaneous Necrotizing Venulitis. The most consistent laboratory finding is elevated ESR.
What is the diagnosis for a patient with a biopsy showing fibrin deposition in venules?
The diagnosis is Cutaneous Necrotizing Venulitis. Systemic features to monitor include involvement of the synovia, GI tract, voluntary muscles, peripheral nerves, and kidneys.
What should be evaluated in a patient with palpable purpura and IgA deposition?
Organs to evaluate include the intestines and kidneys.
What biologic agents can be considered for a patient unresponsive to first-line treatments?
Biologic agents to consider include infliximab, adalimumab, etanercept, and rituximab.
What is the diagnosis for a patient with a biopsy showing endothelial-cell swelling and necrosis?
The diagnosis is Cutaneous Necrotizing Venulitis. This finding suggests endothelial activation and damage.
What does a biopsy showing hypogranulated mast cells and macrophages indicate?
The diagnosis is Cutaneous Necrotizing Venulitis. These findings indicate active inflammation and vessel damage.